A synthetic biomarker, which is a nanoparticle that works with tumor proteins to release fragments into the urine for detection, helps the MIT-developed test create a much clearer signal that natural biomarkers in the bloodstream don’t offer.
Get the full story on our sister site, Medical Design & Outsourcing.